Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Current T₁ and T₂ mapping techniques applied with simple thresholds cannot discriminate acute from chronic myocadial infarction on an individual patient basis: a pilot study.

von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer MA, Wassmuth R, Rudolph A, Utz W, Traber J, Greiser A, Niendorf T, Schulz-Menger J.

BMC Med Imaging. 2016 Apr 29;16:35. doi: 10.1186/s12880-016-0135-y.

2.

Prospective, randomized comparison of gadopentetate and gadobutrol to assess chronic myocardial infarction applying cardiovascular magnetic resonance.

Rudolph A, Messroghli D, von Knobelsdorff-Brenkenhoff F, Traber J, Schüler J, Wassmuth R, Schulz-Menger J.

BMC Med Imaging. 2015 Nov 17;15:55. doi: 10.1186/s12880-015-0099-3.

3.

Analysis of Documentation Speed Using Web-Based Medical Speech Recognition Technology: Randomized Controlled Trial.

Vogel M, Kaisers W, Wassmuth R, Mayatepek E.

J Med Internet Res. 2015 Nov 3;17(11):e247. doi: 10.2196/jmir.5072.

4.

[Endorsement of risk management and patient safety by certification of conformity in health care quality assessment].

Waßmuth R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Jan;58(1):38-44. doi: 10.1007/s00103-014-2084-3. German.

PMID:
25412583
5.

Cardiac magnetic resonance imaging of congenital bicuspid aortic valves and associated aortic pathologies in adults.

Wassmuth R, von Knobelsdorff-Brenkenhoff F, Gruettner H, Utz W, Schulz-Menger J.

Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):673-9. doi: 10.1093/ehjci/jet275. Epub 2014 Jan 21.

PMID:
24451178
6.

Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.

Rudolph A, von Knobelsdorff-Brenkenhoff F, Wassmuth R, Prothmann M, Utz W, Schulz-Menger J.

J Magn Reson Imaging. 2014 May;39(5):1153-60. doi: 10.1002/jmri.24264. Epub 2013 Oct 22.

PMID:
24151119
7.

Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications.

von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer MA, Wassmuth R, Greiser A, Schwenke C, Niendorf T, Schulz-Menger J.

J Cardiovasc Magn Reson. 2013 Jun 18;15:53. doi: 10.1186/1532-429X-15-53.

8.

Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema.

Wassmuth R, Prothmann M, Utz W, Dieringer M, von Knobelsdorff-Brenkenhoff F, Greiser A, Schulz-Menger J.

J Cardiovasc Magn Reson. 2013 Mar 27;15:27. doi: 10.1186/1532-429X-15-27.

9.

Single-centre survey of the application of cardiovascular magnetic resonance in clinical routine.

von Knobelsdorff-Brenkenhoff F, Bublak A, El-Mahmoud S, Wassmuth R, Opitz C, Schulz-Menger J.

Eur Heart J Cardiovasc Imaging. 2013 Jan;14(1):62-8. doi: 10.1093/ehjci/jes125. Epub 2012 Jun 26.

PMID:
22736714
10.

Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.

Wassmuth R.

Cardiovasc Diagn Ther. 2012 Jun;2(2):128-37. doi: 10.3978/j.issn.2223-3652.2012.04.04. Review.

11.

Late gadolinium enhancement in left ventricular dysfunction after trastuzumab.

Wassmuth R, Schulz-Menger J.

J Am Coll Cardiol. 2011 Dec 13;58(25):2697-8; author reply 2699-700. doi: 10.1016/j.jacc.2011.06.071. No abstract available.

12.

Cardiovascular magnetic resonance imaging of myocardial inflammation.

Wassmuth R, Schulz-Menger J.

Expert Rev Cardiovasc Ther. 2011 Sep;9(9):1193-201. doi: 10.1586/erc.11.118. Review.

PMID:
21932962
13.

Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Wassmuth R, Abdel-Aty H, Bohl S, Schulz-Menger J.

Eur Radiol. 2011 Aug;21(8):1643-50. doi: 10.1007/s00330-011-2109-3. Epub 2011 Mar 29.

PMID:
21720941
14.

A pilot study of chronic, low-dose epoetin-{beta} following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure.

Bergmann MW, Haufe S, von Knobelsdorff-Brenkenhoff F, Mehling H, Wassmuth R, Münch I, Busjahn A, Schulz-Menger J, Jordan J, Luft FC, Dietz R.

Eur J Heart Fail. 2011 May;13(5):560-8. doi: 10.1093/eurjhf/hfr002.

15.

Influence of the HLA-DRB1 genotype on antibody development to interferon beta in multiple sclerosis.

Buck D, Cepok S, Hoffmann S, Grummel V, Jochim A, Berthele A, Hartung HP, Wassmuth R, Hemmer B.

Arch Neurol. 2011 Apr;68(4):480-7. doi: 10.1001/archneurol.2011.65.

PMID:
21482927
16.

An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging.

Messroghli DR, Rudolph A, Abdel-Aty H, Wassmuth R, Kühne T, Dietz R, Schulz-Menger J.

BMC Med Imaging. 2010 Jul 30;10:16. doi: 10.1186/1471-2342-10-16.

17.

Aortic dilatation in patients with prosthetic aortic valve: comparison of MRI and echocardiography.

von Knobelsdorff-Brenkenhoff F, Rudolph A, Wassmuth R, Abdel-Aty H, Schulz-Menger J.

J Heart Valve Dis. 2010 May;19(3):349-56.

PMID:
20583398
18.

Assessment of mitral bioprostheses using cardiovascular magnetic resonance.

von Knobelsdorff-Brenkenhoff F, Rudolph A, Wassmuth R, Schulz-Menger J.

J Cardiovasc Magn Reson. 2010 Jun 23;12:36. doi: 10.1186/1532-429X-12-36.

19.

Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.

Wermke M, Maiwald S, Schmelz R, Thiede C, Schetelig J, Ehninger G, Bornhäuser M, Wassmuth R.

Biol Blood Marrow Transplant. 2010 Dec;16(12):1718-27. doi: 10.1016/j.bbmt.2010.06.001. Epub 2010 Jun 9.

20.

Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders.

Zhao S, Wehner R, Bornhäuser M, Wassmuth R, Bachmann M, Schmitz M.

Stem Cells Dev. 2010 May;19(5):607-14. doi: 10.1089/scd.2009.0345. Review.

PMID:
19824807

Supplemental Content

Loading ...
Support Center